Your Followed Topics

5.3M est. views10.71%
sports22h ago

https://www.tmz.com/2025/10/30/oklahoma-city-thunder-nikola-topic-testicular-cancer/https://bleacherreport.com/articles/25271843-thunders-nikola-topic-diagnosed-testicular-cancer-undergoing-chemotherapyhttps://www.espn.com/nba/story/_/id/46782473/thunder-nikola-topic-being-treated-testicular-cancer
Tmz.com and 19 more
www.tmz.com
Open in Tmz.com
Highlights
  • Oklahoma City Thunder guard Nikola Topic has been diagnosed with testicular cancer and is undergoing chemotherapy, with the team prioritizing his health and privacy as he works through treatment.
  • Doctors are optimistic about Topic's long-term outlook, with no fixed timetable for his return as he battles cancer.
  • There is no set timeline for Topic's return to action, and the Thunder emphasize a careful, phased path to recovery.

Virality Score Timeline

Vote 41
0

References

Oklahoma City Thunder Guard Nikola Topic Diagnosed With Testicular Cancer

Oklahoma City Thunder Guard Nikola Topic Diagnosed With Testicular Cancer

Thunder's Nikola Topic Diagnosed with Testicular Cancer, Undergoing Chemotherapy

Thunder's Nikola Topic Diagnosed with Testicular Cancer, Undergoing Chemotherapy

Thunder's Topic in treatment for testicular cancer

Thunder's Topic in treatment for testicular cancer

NBA First-Round Pick Gets Cancer Diagnosis At Age 20

NBA First-Round Pick Gets Cancer Diagnosis At Age 20

OKC Thunder Guard Nikola Topic Diagnosed with Testicular Cancer

OKC Thunder Guard Nikola Topic Diagnosed with Testicular Cancer

Thunder guard Nikola Topic, 20, undergoing treatment for testicular cancer

Thunder guard Nikola Topic, 20, undergoing treatment for testicular cancer

Thunder's Nikola Topić undergoing chemotherapy for testicular cancer

Thunder's Nikola Topić undergoing chemotherapy for testicular cancer

Nikola Topic: Oklahoma City Thunder guard diagnosed with testicular cancer and undergoing chemotherapy

Nikola Topic: Oklahoma City Thunder guard diagnosed with testicular cancer and undergoing chemotherapy

Thunder guard Nikola Topić getting treatment for testicular cancer

Thunder guard Nikola Topić getting treatment for testicular cancer

Oklahoma City Thunder's Nikola Topić Diagnosed with Testicular Cancer at 20

Oklahoma City Thunder's Nikola Topić Diagnosed with Testicular Cancer at 20

Nikola Topic: Oklahoma City Thunder guard, 20, diagnosed with cancer

Nikola Topic: Oklahoma City Thunder guard, 20, diagnosed with cancer

Oklahoma City Thunder guard Nikola Topic diagnosed with testicular cancer and undergoing chemotherapy | CNN

Oklahoma City Thunder guard Nikola Topic diagnosed with testicular cancer and undergoing chemotherapy | CNN

NBA champion diagnosed with cancer at age 20

NBA champion diagnosed with cancer at age 20

Thunder's Nikola Topic isn't only NBA player to be diagnosed with testicular cancer during career

Thunder's Nikola Topic isn't only NBA player to be diagnosed with testicular cancer during career

Thunder's Nikola Topic undergoing chemotherapy treatment for testicular cancer

Thunder's Nikola Topic undergoing chemotherapy treatment for testicular cancer

NBA star's shock cancer diagnosis revealed as he begins chemotherapy

NBA star's shock cancer diagnosis revealed as he begins chemotherapy

OKC Thunder’s Nikola Topić diagnosed with testicular cancer

OKC Thunder’s Nikola Topić diagnosed with testicular cancer

Nikola Topic Begins Chemotherapy After Testicular Cancer Diagnosis

Nikola Topic Begins Chemotherapy After Testicular Cancer Diagnosis

Nikola Topic del Thunder es diagnosticado con cáncer testicular y recibe quimioterapia

Nikola Topic del Thunder es diagnosticado con cáncer testicular y recibe quimioterapia

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 813 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement